A critical advance in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This crucial tumor protector protein is frequently inactivated in various types of tumors, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research